Physician profile
Kenneth L Johnson
NPI 1124061783
$1,194.40
in general payments reported to CMS, 2019-2025
28 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $41.09 · 2021: $49.16 · 2022: $251 · 2023: $164 · 2024: $218 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $335.94 | 2019-2025 | Wegovy |
| Amgen INC. | $148.23 | 2019-2025 | Otezla, Otezla, Repatha |
| Lilly USA, LLC | $61.03 | 2023-2024 | Jardiance, Zepbound, Reyvow |
| Optinose US, INC. | $57.30 | 2022-2025 | |
| Ucb, INC. | $55.16 | 2019-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $54.88 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.44 | 2021-2023 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $42.33 | 2021-2024 | Dupixent |
| Medtronic, INC. | $33.67 | 2023-2024 | Propel, Pteye Parathyroid Detection System |
| Genzyme Corporation | $32.83 | 2022 | |
| Smith+Nephew, INC. | $30.54 | 2019 | |
| Abbott Laboratories | $29.47 | 2025 | Jot Dx |
| Ethicon US, LLC | $25.55 | 2019 | |
| Inspire Medical Systems, INC. | $23.30 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $22.42 | 2024 | Rexulti |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $21.18 | 2025 | Saphnelo |
| Eisai INC. | $16.80 | 2024 | |
| Aerin Medical INC. | $15.59 | 2019 | |
| Sandoz INC. | $15.34 | 2023 | Hyrimoz |
| Exact Sciences Corporation | $15.23 | 2025 | Cologuard Collection Kit |
| Csl Behring | $14.76 | 2020 | |
| Nevro Corp. | $14.75 | 2024 | Senza |
| Antares Pharma, INC. | $13.99 | 2022 | |
| Sanofi Pasteur INC. | $13.44 | 2019 | |
| Phadia US INC. | $13.31 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.24 | 2019 | |
| Janssen Biotech, INC. | $11.94 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.